Winter Jordan M, Brody Jonathan R, Kern Scott E
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.
Cancer Biol Ther. 2006 Apr;5(4):360-70. doi: 10.4161/cbt.5.4.2552. Epub 2006 Apr 1.
In an accompanying paper, we review the theoretical principles of tumor mutations and the observed patterns of mutations in the cancer literature. These patterns are discussed in the context of a perceived dichotomy in quality that exists among mutation reports. Due to the frequency of mis-reporting, a systematic approach to the somatic mutation literature in human cancer is needed. We propose a multiple-criterion numerical tool, referred to as the scoring SISTM (System for Intragenic Somatic Tumor Mutations), which effectively discriminates promising and unpromising somatic mutation reports in human cancer. Reports are assessed on 12 criteria, and are given a final score of 15 or less. Scores in the range of 10 to 15 are suggestive of well-presented reports of disease-inducing somatic mutations. Reports with scores less than 10 should be viewed with skepticism.
在一篇随附论文中,我们回顾了肿瘤突变的理论原理以及癌症文献中观察到的突变模式。这些模式是在突变报告中存在的质量二分法背景下进行讨论的。由于错误报告的频率,需要一种系统的方法来处理人类癌症中的体细胞突变文献。我们提出了一种多标准数值工具,称为评分SISTM(基因内体细胞肿瘤突变系统),它能有效区分人类癌症中有前景和无前景的体细胞突变报告。报告根据12项标准进行评估,最终得分在15分及以下。得分在10至15分之间表明是关于疾病诱导体细胞突变的表述良好的报告。得分低于10分的报告应持怀疑态度。